AURORA LAS ENCINAS BHS — History
CCN 054078 | 3-year financial timeline | COVID resilience: 45/100
🛡️ Public data only — no PHI permitted on this instance.
$34M
Latest Revenue (FY2022)
+4.2%
Revenue CAGR (3yr)
3.7%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $31M | $34M | $34M | +0.7% | +4.2% |
| Operating Expenses | $31M | $32M | $33M | +4.0% | +3.5% |
| Operating Margin | 2.3% | 6.7% | 3.7% | -45.0% | +26.2% |
| Net Income | $1M | $2M | $1M | -44.7% | +31.5% |
| Licensed Beds | 118 | 118 | 96 | -18.6% | -9.8% |
| Total Patient Days | 29,674 | 31,558 | 31,921 | +1.2% | +3.7% |
| Medicare Day % | 15% | 14% | 8% | -42.5% | -27.2% |
| Medicaid Day % | 1% | 1% | 1% | -6.1% | -28.3% |
COVID Impact & Recovery
Resilience Score: 45/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: +8.6% ($31M → $34M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▼ Declining
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+4.2%
This Hospital
+7.6%
State Avg
Latest Margin
3.7%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $36M | 4.4% |
| FY2024 (proj) | $37M | 5.1% |
| FY2025 (proj) | $38M | 5.8% |